Small Molecule Therapies for Rheumatoid Arthritis: Global Markets to 2022

Report Code: PHM195A

Publish Date: Apr 2018

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global small molecule therapies for rheumatoid arthritis market totaled $1.7 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 6.6% for the period of 2017-2022.

Report Includes

  • 95 data tables
  • Country specific data and analysis for China, India, Japan, Australia, United Kingdom, Germany, France, Italy, Spain, Russia, USA, and Brazil
  • Identification of segments with high growth potential and their future applications
  • Explanation of major drivers and regional dynamics of the market and current trends within the industry
  • Detailed profiles of major vendors in the market, including AbbVie Inc., Amgen Inc., Bristol-Myers Squibb, F. Hoffmann-La Roche AG and Pfizer Inc.

Report Scope

This research report categorizes the small molecule therapies for rheumatoid arthritis market by product type. Product type include disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs and corticosteroids.

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Analyst Credentials

BCC Research analysts craft reference reports with a unique end noted referencing methodology, which allows users to cross reference and trace market numbers back to their source. These individuals are experts in secondary research and primary forecasting - compiling and layering existing data with their original research and analysis. The team has decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Small Molecule Therapies for Rheumatoid Arthritis: Global Markets to 2022171Free
Chapter- 1: Introduction5Free
Chapter- 2: Summary and Highlights2Free
Chapter- 3: Small Molecule Therapies for Rheumatoid Arthritis Market Characteristics2Free
Chapter- 4: Small Molecule Therapies for Rheumatoid Arthritis Market Size and Growth5Free
Chapter- 5: Small Molecule Therapies for Rheumatoid Arthritis Market Trends and Strategies2Free
Chapter- 6: PESTLE Analysis6Free
Chapter- 7: Small Molecule Therapies for Rheumatoid Arthritis Market Segmentation4Free
Chapter- 8: Small Molecule Therapies for Rheumatoid Arthritis Market Regional and Country Analysis9Free
Chapter- 9: Global Small Molecule Therapies for Rheumatoid Arthritis Market Comparison with Macro Economic Factors3Free
Chapter- 10: Asia-Pacific Small Molecule Therapies for Rheumatoid Arthritis Market8Free
Chapter- 11: Asia-Pacific Small Molecule Therapies for Rheumatoid Arthritis Market: Country Analysis24Free
Chapter- 12: Western Europe Small Molecule Therapies for Rheumatoid Arthritis Market8Free
Chapter- 13: Western Europe Small Molecule Therapies for Rheumatoid Arthritis Market: Country Analysis25Free
Chapter- 14: Eastern Europe Small Molecule Therapies for Rheumatoid Arthritis Market8Free
Chapter- 15: Eastern Europe Small Molecule Therapies for Rheumatoid Arthritis Market: Country Analysis5Free
Chapter- 16: North America Small Molecule Therapies for Rheumatoid Arthritis Market8Free
Chapter- 17: North America Small Molecule Therapies for Rheumatoid Arthritis Market: Country Analysis5Free
Chapter- 18: South America Small Molecule Therapies for Rheumatoid Arthritis Market8Free
Chapter- 19: South America Small Molecule Therapies for Rheumatoid Arthritis Market: Country Analysis5Free
Chapter- 20: Middle East Small Molecule Therapies for Rheumatoid Arthritis Market7Free
Chapter- 21: Africa Small Molecule Therapies for Rheumatoid Arthritis Market6Free
Chapter- 22: Small Molecule Therapies for Rheumatoid Arthritis Market Customer Information2Free
Chapter- 23: Small Molecule Therapies for Rheumatoid Arthritis Market Competitive Landscape11Free
Chapter- 24: Key Mergers and Acquisitions in the Small Molecule Therapies for Rheumatoid Arthritis Market1Free
Chapter- 25: APPENDIX2Free

Related Reports

Global Markets for Generic Drugs

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM009K

The global market for generic drugs is expected to grow from $435.3 billion in 2023 and projected to reach $655.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 to 2028.

Autoimmune Disease Diagnostics: Global Markets

Published - Jan 2024 | Publisher - BCC Publishing | Code - PHM160C

The global market for autoimmune disease diagnostics is estimated to increase from $14.8 billion in 2023 to reach $17.9 billion by 2028, at a compound annual growth rate (CAGR) of 3.9% from 2023 through 2028.

Global Market for Pain Management Drugs and Devices

Published - Dec 2023 | Publisher - BCC Publishing | Code - HLC026G

The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.

Autoimmune Disorder Therapies: Global Markets

Published - Nov 2020 | Publisher - BCC Publishing | Code - PHM240A

The global market for autoimmune disorder therapies should grow from $53.2 billion in 2019 to $90.7 billion by 2024 with a compound annual growth rate (CAGR) of 11.2% for the period of 2019-2024.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 95

  • Summary Table: Global Small Molecule Therapies for Rheumatoid Arthritis Market, Through 2022
  • Table 1: Global Small Molecule Therapies for Rheumatoid Arthritis Historic Market, Through 2017
  • Table 2: Global Small Molecule Therapies for Rheumatoid Arthritis Market Forecast, Through 2022
  • Table 3: Global Small Molecule Therapies for Rheumatoid Arthritis Market, by Segment, 2017
  • Table 4: Global Small Molecule Therapies for Rheumatoid Arthritis Market Historic and Forecast Growth Rate, by Segment, Through 2022
  • Table 5: Global Small Molecule Therapies for Rheumatoid Arthritis Market, by Region, 2017
  • Table 6: Global Small Molecule Therapies for Rheumatoid Arthritis Market Historic and Forecast Growth Rate, by Region, Through 2022
  • Table 7: Global Small Molecule Therapies for Rheumatoid Arthritis Market Segmentation, by Region, 2017
  • Table 8: Global Small Molecule Therapies for Rheumatoid Arthritis Market, by Country, 2017
  • Table 9: Global Small Molecule Therapies for Rheumatoid Arthritis Market Historic and Forecast Growth Rate, by Country, 2013-2022
  • Table 10: Global Small Molecule Therapies for Rheumatoid Arthritis Market Segmentation, by Country, 2017
Sample Report

Recent Reports

Disease-Modifying Therapies for Alzheimer’s Disease: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - PHM283A

This report provides an overview of the global and regional markets for disease-modifying therapies for Alzheimer’s disease. It includes global revenue ($ million) for base year data of 2024, estimates for 2025, and CAGR forecasts through 2030.

Global Markets for Allergy Diagnostics and Treatments

Published - Jun 2025 | Publisher - BCC Publishing | Code - PHM026D

The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.

Over-the-Counter (OTC) Drugs, and Vitamins & Dietary Supplements: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - PHM050D

The global market for over-the- counter (OTC) drugs, vitamins and dietary supplements is expected to grow from $276.9 billion in 2025 and is projected to reach $371.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.1% during the forecast period of 2025 to 2030.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

The Global Influenza Market

Published - May 2025 | Publisher - BCC Publishing | Code - PHM049F

The global influenza market is expected to grow from $9.0 billion in 2024 and is projected to reach $12.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.2% during the forecast period of 2024 to 2029. 

Top Trending Reports

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

2024 Medical Devices Research Review

Published - Mar 2025 | Publisher - BCC Publishing | Code - MDS060B

The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Small Molecule Therapies for Rheumatoid Arthritis: Global Markets to 2022
Customize Report